Anti-CD19 CAR T-cells with a CRISPR/Cas9-mediated T-cell receptor knockout show high functionality in the absence of alloreactivity in vitro

被引：0
|
作者：
Stenger, Dana
Stief, Tanja
Kaeuferle, Theresa
Willier, Semjon Manuel
Rataj, Felicitas
Schober, Kilian
Lotfi, Ramin
Wagner, Beate
Busch, Dirk H.
Kobold, Sebastian
Blaeschke, Franziska
Feuchtinger, Tobias
机构：
[1] Univ Munich, Munich, Germany
[2] Univ Munich, Hauner Childrens Hosp, Med Ctr, Munich, Germany
[3] Ctr Integrated Prot Sci Munich, Munich, Germany
[4] Div Clin Pharmacol, Munich, Germany
[5] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany
[6] Univ Hosp Ulm, Inst Transfus Med, Ulm, Germany
[7] Klinikum LMU Munchen, Dept Transfus Med Cell Therapeut & Hemostaseol, Munich, Germany
来源：
CANCER IMMUNOLOGY RESEARCH | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR18-A043
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A043
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Anti-CD19 CAR T-cells
    Smith, Lan-Lan
    [J]. LANCET ONCOLOGY, 2017, 18 (01): : 26 - 26
  • [2] Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR
    Stenger, Dana
    Stief, Tanja A.
    Kaeuferle, Theresa
    Willier, Semjon
    Rataj, Felicitas
    Schober, Kilian
    Vick, Binje
    Lotfi, Ramin
    Wagner, Beate
    Gruenewald, Thomas G. P.
    Kobold, Sebastian
    Busch, Dirk H.
    Jeremias, Irmela
    Blaeschke, Franziska
    Feuchtinger, Tobias
    [J]. BLOOD, 2020, 136 (12) : 1407 - 1418
  • [3] CRISPR/Cas9-Mediated Diacylglycerol Kinase Knockout Potentiates Anti-Tumor Efficacy of Human Chimeric Antigen Receptor T-Cells
    Jung, In-Young
    Kim, Yoon-Young
    Yu, Ho-Sung
    Kim, Seokjoong
    Thon, Jonathan N.
    Lee, Jungmin
    [J]. BLOOD, 2017, 130
  • [4] CRISPR/Cas9-Mediated Knockout of DGK Improves Anti-Tumor Activities of Human T Cells
    Kim, Yoon-Young
    Jung, In-Young
    Yu, Ho-Sung
    Kim, Seokjoong
    Lee, Jungmin
    [J]. MOLECULAR THERAPY, 2018, 26 (05) : 55 - 55
  • [5] CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy
    Park, Hyeseon
    Kang, Yoo Kyung
    Shim, Gayong
    [J]. PHARMACEUTICS, 2024, 16 (03)
  • [6] CRISPR/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells
    Elahe Kamali
    Fatemeh Rahbarizadeh
    Zohreh Hojati
    Morten Frödin
    [J]. BMC Biotechnology, 21
  • [7] CRISPR/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells
    Kamali, Elahe
    Rahbarizadeh, Fatemeh
    Hojati, Zohreh
    Frodin, Morten
    [J]. BMC BIOTECHNOLOGY, 2021, 21 (01)
  • [8] CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells
    Jung, In-Young
    Kim, Yoon-Young
    Yu, Ho-Sung
    Lee, Myoungsoo
    Kim, Seokjoong
    Lee, Jungmin
    [J]. CANCER RESEARCH, 2018, 78 (16) : 4692 - 4703
  • [9] Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy
    Zhang, Wen-ying
    Liu, Yang
    Wang, Yao
    Nie, Jing
    Guo, Ye-lei
    Wang, Chun-meng
    Dai, Han-ren
    Yang, Qing-ming
    Wu, Zhi-qiang
    Han, Wei-dong
    [J]. GENE THERAPY, 2018, 25 (03) : 198 - 204
  • [10] Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy
    Wen-ying Zhang
    Yang Liu
    Yao Wang
    Jing Nie
    Ye-lei Guo
    Chun-meng Wang
    Han-ren Dai
    Qing-ming Yang
    Zhi-qiang Wu
    Wei-dong Han
    [J]. Gene Therapy, 2018, 25 : 198 - 204
12345